Dr. Haas-Kogan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
75 Francis St
Boston, MA 02115Phone+1 617-632-2291Fax+1 617-632-2290- Is this information wrong?
Education & Training
- University of California (San Francisco)Residency, Radiation Oncology, 1992 - 1997
- California Pacific Medical CenterInternship, Internal Medicine, 1991 - 1992
- University of California San Francisco School of MedicineClass of 1991
Certifications & Licensure
- MA State Medical License 2015 - 2026
- ME State Medical License 2020 - 2026
- CA State Medical License 1993 - 2025
- FL State Medical License 2023 - 2025
- CT State Medical License 2022 - 2025
- RI State Medical License 2022 - 2024
- NH State Medical License 2022 - 2024
- American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
Clinical Trials
- PNOC 001: Phase II Study of Everolimus for Recurrent or Progressive Low-grade Gliomas in Children Start of enrollment: 2012 Dec 13
Publications & Presentations
PubMed
- A Multi-Institutional Survey of Radiation Oncology Professionals' Knowledge, Attitudes, and Practice Behaviors Toward Sexual and Gender Minority Patients With Cancer.Beck Gold, Pin-Ji Lei, Alicia C Smart, Sophia C Kamran, Daphne A Haas-Kogan, Idalid Franco, Anthony L Zietman, Jennifer Y Wo> ;Advances in Radiation Oncology. 2024 May 1
- Vorinostat, temozolomide or bevacizumab with irradiation and maintenance BEV/TMZ in pediatric high-grade glioma: A Children's Oncology Group Study.Rishi R Lulla, Allen Buxton, Mark D Krailo, Margot A Lazow, Daniel R Boue, James L Leach, Tong Lin, James I Geller, Shiva Senthil Kumar, Marina N Nikiforova, Uma Chand...> ;Neuro-Oncology Advances. 2024 Mar 14
- Aurora Kinase A inhibition enhances DNA damage and tumor cell death withI-MIBG therapy in high-risk neuroblastoma.Kumar, P., Koach, J., Nekritz, E., Mukherjee, S., Braun, B., DuBois, S., Nasholm, N., Matthay, K., Weiss, W., Gustafson, C., Seo, Y., Haas-Kogan, D.> ;Research Square. 2024 Jan 18
- Join now to see all
Journal Articles
- Clinical Characteristics, Experiences, and Outcomes of Transgender Patients with CancerDanielle S Bitterman, Daphne A Haas-Kogan, JAMA Oncology
- Race Disparities in Proton Radiotherapy Use for Cancer Treatment in Patients Enrolled in Children’s Oncology Group TrialsDanielle S Bitterman, Stephanie A Terezakis, Daphne A Haas-Kogan, JAMA Oncology
Authored Content
- Race Disparities in Proton Radiotherapy Use for Cancer Treatment in Patients Enrolled in Children’s Oncology Group TrialsAugust 2020
Press Mentions
- Vulnerability in Brain Tumors May Open Door to New TreatmentsSeptember 26th, 2022
- Channeling JFK in Boston Visit, Biden Breathes New Life into Cancer ‘Moonshot’September 12th, 2022
- Christ Hospital Becomes Newest Member of Dana-Farber Brigham Cancer Care CollaborativeJuly 6th, 2022
- Join now to see all
Professional Memberships
- Member
- Member
- Member
- ASTROMember
- Member
- Member
- Member
Other Languages
- Hebrew
Hospital Affiliations
- Brigham and Women's HospitalBoston, Massachusetts
External Links
- BWH Radiation Oncologyhttp://www.brighamandwomens.org/Departments_and_Services/surgery/services/urology/Radiation-Therapy.aspx
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: